Clinical Trials Directory

Trials / Unknown

UnknownNCT06006689

Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)

A Randomized, Double-blind, Multi-center, Standardise-loaded, Placebo-parallel Controlled Clinical Trial of Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
228 (estimated)
Sponsor
Tasly Pharmaceutical Group Co., Ltd · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the efficacy and Safety of QiShen YiQi Dripping Pills in the treatment of Diabetic Kidney Disease (syndrome of Qi deficiency with blood stasis)

Conditions

Interventions

TypeNameDescription
DRUGQishen Yiqi Dripping Pills placebo 3 bagsQishen Yiqi Dripping Pills placebo contain Qishen Yiqi dripping pills placebo 3 bags(0.52g dripping pills placebo per bag),take orally after meals, 3 times a day for 12weeks
DRUGLow dose Qishen Yiqi Dripping Pills 3 bagsLow dose Qishen Yiqi Dripping Pills contain Qishen Yiqi dripping pills 2 bags(0.52g dripping pills per bag) and Qishen Yiqi dripping pills placebo 1 bag(0.52g dripping pills placebo per bag),take orally after meals, 3 times a day for 12weeks
DRUGHigh dose Qishen Yiqi Dripping Pills 3 bagsHigh dose Qishen Yiqi Dripping Pills contain Qishen Yiqi dripping pills 3 bags(0.52g dripping pills per bag),take orally after meals, 3 times a day for 12weeks

Timeline

Start date
2023-09-04
Primary completion
2025-09-01
Completion
2025-09-01
First posted
2023-08-23
Last updated
2024-03-13

Locations

16 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06006689. Inclusion in this directory is not an endorsement.